MRP ₹6672
(Inclusive of all Taxes)
₹1000.8 Cashback (15%)
Extra 15% Off with Bank Offers
Composition :
PEGFILGRASTIM-6MG
Manufacturer/Marketer :
Del Trade International Pvt Ltd
Consume Type :
Parenteral
Expires on or after :
Return Policy :
Not Returnable
Secure Payment
Trusted by 8 Crore Indians
Genuine Products
Author Details
_0.jpg?tr=q-85,f-webp,w-100,dpr-1,c-at_max "Santoshini Reddy G")
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Alcohol
Pregnancy
Breast Feeding
Driving
Liver
Kidney
Children
Product Substitutes
Drug-Drug Interactions
No Drug - Drug interactions found in our data. We may lack specific data on this medicine and are actively working to update our database. Consult your doctor for personalized advice
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
PEGFILGRASTIM-6MGUnspecified nephritic syndrome
Severe
PEGFILGRASTIM-6MGMyeloid leukaemia
Severe
Drug-Diseases Interactions
Login/Sign Up
PEGFILGRASTIM-6MGUnspecified nephritic syndrome
Severe
How does the disease interact with Pegrow 6 mg/0.6 ml Injection:
Glomerulonephritis can be caused by Pegrow 6 mg/0.6 ml Injection. Swelling of the face or ankles, blood or urine with a black colour, or a reduction in urine output are all symptoms.
How to manage the interaction:
If you have swelling of the face or ankles, dark-coloured urine, or blood in the urine, or a decrease in urine production while using Pegrow 6 mg/0.6 ml Injection, inform your doctor immediately as these may be signs and symptoms of glomerulonephritis (inflammation of tiny filters in the kidneys).
Glomerulonephritis can be caused by Pegrow 6 mg/0.6 ml Injection. Swelling of the face or ankles, blood or urine with a black colour, or a reduction in urine output are all symptoms.
How to manage the interaction:
If you have swelling of the face or ankles, dark-coloured urine, or blood in the urine, or a decrease in urine production while using Pegrow 6 mg/0.6 ml Injection, inform your doctor immediately as these may be signs and symptoms of glomerulonephritis (inflammation of tiny filters in the kidneys).
PEGFILGRASTIM-6MGMyeloid leukaemia
Severe
How does the disease interact with Pegrow 6 mg/0.6 ml Injection:
Colony stimulating agents predominantly promote neutrophil development, they may also potentially promote tumour growth, especially in myeloid malignancies. Patients with myeloid tumours should receive this medication therapy with caution.
How to manage the interaction:
Pegrow 6 mg/0.6 ml Injection should be used with caution in patients with myeloid tumors.
Colony stimulating agents predominantly promote neutrophil development, they may also potentially promote tumour growth, especially in myeloid malignancies. Patients with myeloid tumours should receive this medication therapy with caution.
How to manage the interaction:
Pegrow 6 mg/0.6 ml Injection should be used with caution in patients with myeloid tumors.
PEGFILGRASTIM-6MGOther disorders of white blood cells
Severe
How does the disease interact with Pegrow 6 mg/0.6 ml Injection:
Growth factors for neutrophil progenitor cells include Pegrow 6 mg/0.6 ml Injection. They should not be administered to anyone who have leukocytosis. Treatment should be stopped or the dosage lowered if excessive white blood cell counts develop while receiving CSF therapy.
How to manage the interaction:
Pegrow 6 mg/0.6 ml Injection is not recommended for leukocytosis (high white blood cell count) patients.
Growth factors for neutrophil progenitor cells include Pegrow 6 mg/0.6 ml Injection. They should not be administered to anyone who have leukocytosis. Treatment should be stopped or the dosage lowered if excessive white blood cell counts develop while receiving CSF therapy.
How to manage the interaction:
Pegrow 6 mg/0.6 ml Injection is not recommended for leukocytosis (high white blood cell count) patients.
All Substitutes & Brand Comparisons
RX
Out of StockImupeg 6mg Injection
Abbott India Ltd
₹6984.45
(₹954.54/ 1ml)
82% CHEAPERRX
Out of StockPeg-Nustim 6 mg Injection 0.6 ml
Sayre Therapeutics Pvt Ltd
₹5491
(₹4502.62/ 1ml)
17% CHEAPERRX
Peg-Axokine 6 mg Injection 0.6 ml
Axiommax Oncology Pvt Ltd
₹4471.5
(₹6111.0/ 1ml)
11% COSTLIER
Have a query?